News - GW Pharmaceuticals, Almirall

Filter

Popular Filters

Agreement reached for Sativex pricing in Germany

25-09-2013

A German unit of Spain’s largest drugmaker Almirall, Hermal GmbH and Germany’s National Association…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalPricingSativex

Almirall pays GW Pharma milestone on Sativex; reports 1st-qtr results

07-05-2013

UK-based GW Pharmaceuticals (AIM: GWP) says that it has received commercialization approval for its cannabinoid-based…

AlmirallEuropeFinancialGW PharmaceuticalsNeurologicalPharmaceuticalRegulationSativex

Almirall could pull Sativex from German market due to inadequate pricing

20-03-2013

Almirall (ALM: MC), Spain's largest pharma company and the licensee for UK-based GW Pharmaceuticals'…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalPricingSativex

Highlights from ECTRIMS include new data for Gilenya, Sativex and Aubagio

14-10-2012

New data presented at the 28th congress of the European Committee for Treatment and Research in Multiple…

AlmirallAubagioBiotechnologyGenzymeGilenyaGW PharmaceuticalsNeurologicalNovartisPharmaceuticalResearchSanofiSativex

Spanish reforms and generics hit Almirall's 1st-qtr; Sativex progress

09-05-2012

Spain's leading drugmaker Almirall (ALM: MC) has reported a 5.9% decrease in sales for the first quarter…

AlmirallEuropeFinancialGW PharmaceuticalsNeurologicalPharmaceuticalRegulationSativex

No proof of added benefit of Sativex, says German IQWiG

17-04-2012

In an early benefit assessment under to the German Act on the Reform of the Market for Medicinal Products…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalPricingRegulationSativex

GW Pharma and Almirall extend Sativex deal to Mexico

15-03-2012

UK-based GW Pharmaceuticals (AIM: GWP) announces that it has signed an amendment to its cannabis-based…

AlmirallFinancialGW PharmaceuticalsLicensingNeurologicalPharmaceuticalSativexSouth America

GW Pharma’s Sativex cleared in Austria

07-02-2012

The UK’s GW Pharmaceuticals’ (AIM: GWP) Sativex (delta-9-tetrahydrocannabinol (THC) and cannabidiol…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalRegulationSativex

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top